Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...

The latest budget proposal to cut anti-obesity medication (AOM) coverage by Medi-Cal will cost the state more in the long run ...

Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...

The White House blamed exposure to environmental toxins, poor nutrition and increased screen time for a decline in Americans’ ...

WeightWatchers teams up with UK weight-loss drug provider CheqUp in a major shift from its traditional dieting model, amid ...

Roll out of weight loss drugs in England could be dramatically sped up to millions of working age adults by making use of ...

After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

Domestic pharmaceutical companies are stepping up in the insulin space. Lupin acquired Lilly’s Huminsulin brand, while Cipla ...

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role ...